Growth Risk Intelligence
B2B SaaS · Seed Stage · Series A in 6–12 months
📋
This Assessment Is For
A Founder · Seed Stage · Goal: Raise a Fundable Series A
SMB traction is real.
It is not the Series A story.
A complete picture of whether current traction sits in a segment that holds up under investor scrutiny, what's at risk if it doesn't, and what changes if it's corrected now.
Current ARR
$310,000
SMB Revenue Share
84%
Net Revenue Retention
91%
Runway
9 months
Identifying details anonymised for illustration. Structure and methodology shown are representative.
Reality
Risk
Readiness
Unlock Sequence
Two Versions of the Next 12 Months
Page 2 of 17 · Before the data, the stakes
A raise is coming. The story isn't ready yet.
This is what the fundraising process actually looks like, told two ways, depending on whether the segment story shifts before the process starts.
If the Narrative Stays SMB-Led
6 Months
Pitch deck goes out built around current ARR mix. Early interest looks strong. Diligence begins, and so do the questions about churn and margin nobody had a clean answer for.
12 Months
The round closes smaller, later, or at a discount, if it closes in this window at all. Capital raised against the wrong segment compounds the original economics problem instead of solving it.
If the Narrative Shifts to Mid-Market
6 Months
3–5 mid-market design partners are actively engaged. The pitch is reframed around the segment that actually scales, backed by early but real evidence.
12 Months
The raise enters process with a defensible story and credible unit economics. Capital gets deployed into the segment with real venture-scale potential from day one.
Business Reality
Page 3 of 17 · Not metrics. A map.
Here is your company. At a glance.
Six layers, one chain. Color shows what's holding, what's straining, and what's actually breaking.
Vision
Clear
↓
Revenue Engine
Working, Wrong Segment
↓
Customers
84% Concentrated in SMB
↓
Product
Validated in Two Segments
↓
Team
Founder-Carried
↓
Capital
9 Months, Raise Pending
Where You Are Today
Page 4 of 17 · Their numbers, not benchmarks
What is actually true about this company's traction.
Real numbers from intake and independent research, not a generic seed-stage benchmark.
Current ARR
$310K
SMB Revenue Share
84%
Highly concentrated
SMB Gross Margin
31%
Below SaaS norm
Mid-Market Pilots
2
NRR
91%
Below 100%
SMB Churn (Annual)
38%
High
CAC Payback
14 mo
Runway
9 mo
What this actually means
$310K in ARR is real. But 84% sits in SMB accounts with 31% gross margin and 38% annual churn, economics that don't scale into a venture-backed growth story. The two mid-market pilots are the most important number on this page: early evidence of fundamentally different unit economics, but not yet enough evidence to build a Series A narrative on.
What We Investigated
Before any conclusion, the research
This wasn't guessed. It was researched.
Every finding in this report is built from a specific set of inputs about this company.
✓
Customer cohort data by segment
✓
Churn & retention by segment
✓
Gross margin by account type
✓
Pilot account interviews
✓
Comparable Series A narratives
✓
Investor diligence patterns
✓
Team structure & capacity
✓
Intake responses
✓
Cap table & runway model
✓
Category fundraising benchmarks
Vision Alignment
Page 6 of 17 · What you're working toward, not just what's wrong
Your goal. What's between you and it.
Your Goal
Raise a Fundable Series A
↓
What Is Preventing It
Segment Concentration Risk
↓
What Must Change
Mid-Market Validation
↓
Expected Outcome
A Fundable Narrative
Primary Growth Friction
Page 7 of 17 · The root cause
Segment Concentration Risk
What the current segment mix is actually producing, and what it will look like to an investor.
Current state, where revenue actually comes from
84% of ARR from SMB accounts under 20 employees · 31% gross margin on SMB vs. an estimated 68% on mid-market pilots · 38% annual SMB churn · No documented mid-market motion, both pilots closed through founder relationships
Observation
This is not a product problem, the product is working in two segments with very different economic profiles. The risk is narrative: a Series A pitch built on $310K of SMB-heavy ARR draws immediate questions about unit economics and retention. A pitch built on the mid-market signal, even at smaller scale, tells a more fundable story.
Can this be fixed before the raise? Yes. The Wiremap Growth Plan sequences exactly how to convert two pilots into a validated segment story within a single fundraising timeline.
The Constraint Stack
One visual. The whole chain.
From the symptom you feel to the cause underneath it.
Every layer here is real. The bottom one is where the leverage is.
The Symptom
Fundraising Risk
Shows Up As
Weak Unit Economics Narrative
Caused By
Segment Concentration in SMB
Which Produces
31% Margin, 38% Churn
Root Cause
No Deliberate Mid-Market Motion
Blind Spot Analysis
Page 9 of 17 · What you no longer need to worry about first
What this is. What it isn't.
Founders often assess themselves in the wrong direction. Here is what the evidence rules out.
You do NOT have
A product-market fit problem
A growth rate problem
A team capability problem
A capital efficiency problem, broadly
You DO have
A segment narrative problem
Why this matters
The two mid-market pilots rule out product-market fit as the constraint, the product clearly works in the right segment. What remains is proof at scale, and proof is the fastest of all these problems to build.
Cost of Inaction
Page 10 of 17 · What this is costing, specifically
Segment concentration has a price. Here it is.
Estimated valuation discount of an SMB-led narrative: 20–35% versus a mid-market-led story at the same ARR
NRR below 100% and 38% churn are typically the first diligence questions raised
Discovering this during the raise, rather than before it, costs 2–4 months of fundraising momentum
In dollar terms
A Series A raised on a corrected mid-market narrative, even at similar headline ARR, is estimated to be worth 20–35% more in valuation than the same numbers presented with an SMB-led story.
Future State Simulator
Page 11 of 17 · Two trajectories, same starting point
Two raises. Same starting ARR.
SMB-Led Narrative
NRR
91%
Gross Margin
31%
Diligence Risk
High
Est. Valuation Discount
20–35%
Mid-Market-Led Narrative
NRR
~108%
Gross Margin
~68%
Diligence Risk
Low
Est. Valuation Discount
None
0
Now
84% SMB concentration
30
30 Days
3–5 design partners engaged
90
90 Days
Mid-market signal strengthens
180
180 Days
Fundable narrative ready
365
12 Months
Capital deployed into right segment
Growth Risk Matrix
Page 12 of 17 · Beyond the named constraint
Six categories. Where else risk concentrates.
A single constraint rarely exists alone. This is a wider scan across the categories that typically threaten companies at this stage.
Market Risk
Low, 28
Product Risk
Low, 22
GTM Risk
High, 71
Founder Risk
Medium, 58
Capital Risk
Medium, 64
Team Risk
Low, 31
Constraint Interdependency
Page 13 of 17 · How one issue creates three others
The segment problem doesn't stay contained.
Segment Concentration
GTM risk, no mid-market motion exists to scale into
Capital risk, runway pressure forces a raise before the story is ready
Founder risk, both pilots closed personally, with no repeatable process yet
Scaling Readiness
Page 14 of 17 · Current vs. next stage
Where you are. Where Series A expects you to be. What's missing.
Current
84% SMB revenue, 2 unproven mid-market pilots, founder-led closing
Next Stage Expectation
A validated, scalable segment with 5+ reference accounts and repeatable economics
The Gap
3–5 more mid-market wins and a documented motion, achievable within one fundraising timeline
Top Five Future Risks
Page 15 of 17 · What breaks next, not what is broken today
If the segment story stays unresolved.
01
Diligence stalls mid-process
Investors build their own cohort model and find the SMB economics before the team can reframe the narrative.
02
Runway forces a worse deal
A 9-month runway leaves limited room to walk away from an unfavorable term sheet.
03
SMB churn accelerates further
At 38% annual churn, the SMB base could shrink meaningfully before mid-market revenue is large enough to offset it.
04
Founder becomes the single point of failure in diligence
Both mid-market wins closing through founder relationships raises a repeatability question investors will ask directly.
05
A smaller round resets future fundraising expectations
A discounted or down-sized Series A makes the next round's bar even harder to clear.
Risk Severity Ranking
Page 16 of 17 · Ranked by what matters most, right now
Impact. Likelihood. Urgency.
RiskImpactLikelihoodUrgency
Diligence stalls mid-processHighHighHigh
Runway forces a worse dealHighMediumHigh
SMB churn acceleratesMediumMediumMedium
Founder single point of failureMediumHighMedium
Smaller round resets expectationsHighMediumLow
Opportunity Heatmap
Page 17 of 17 · Where the leverage actually is
Five levers. Scored on what they'd take.
LeverImpactDifficultyTimeline
Mid-Market Design PartnersHighMedium30–60 days
Segment-Specific NarrativeHighLow30 days
Documented Mid-Market MotionHighMedium60–90 days
SMB Churn ReductionMediumMedium90 days
Investor Pre-BriefingMediumLow30 days
Knowing which lever matters most is only half the challenge. The Wiremap Growth Plan sequences these into a fundraising-timeline-aware plan.
ROI Dashboard
Page 18 of 17 · What gets unlocked
Same ARR. Very different valuation.
SMB-Led Valuation
$5.0M
→
Mid-Market-Led Valuation
$6.5M
Difference
+$1.5M unlocked
Unlock Sequence
Page 19 of 17 · Strategic direction, not execution detail
Three priorities. In order.
Priority 01
Identify and engage 3–5 mid-market design partner candidates
Why it matters
Two pilots prove the segment is viable, the next priority is volume of evidence.
Expected impact
A defensible segment story before the raise begins.
Priority 02
Define the mid-market ICP around a specific trigger event
Why it matters
Both pilots closed through relationships, the real trigger has never been tested deliberately.
Expected impact
Two lucky wins become a repeatable, explainable motion.
Priority 03
Reframe the fundraising narrative around the segment transition
Why it matters
"We have $310K ARR" is a weaker pitch than "we've validated a high-margin segment and are scaling it."
Expected impact
A fundamentally more fundable story using the same underlying facts.
What Comes Next
Page 17 of 17 · What resolving this is worth
Find My Constraint →
ROI Dashboard
The cost of this constraint, quantified.
Every week this constraint stays unresolved is a week the underlying cost compounds. Here is what the numbers look like when the constraint is named, not estimated.
Monthly Cost Unresolved
$22K–$35K
Pipeline inefficiency and conversion loss
6-Month Compounding Cost
$132K–$210K
Across hiring, pipeline, and runway
Value of Resolving It
$280K–$520K
Recovered ARR potential within 12 months
The cost of the assessment in context
This Growth Risk Intelligence report cost $399. The constraint it identified is costing an estimated $22K–$35K every month it stays unresolved. The return on this assessment is not theoretical. It is structural.
Page 18 of 17 · What to do first
Find My Constraint →
Strategic Priorities
Three actions. In this order.
Not ten recommendations. The three moves that address the root constraint in the sequence that creates the most leverage. Start with Priority 01 before moving to 02.
Priority 01 · This Week
Fix the segment concentration before the fundraising process starts
Map your ARR by segment, company size, and industry. Identify which single segment is creating the most concentration risk. Then build a 60-day plan to win one anchor customer from outside that segment.
Priority 02 · This Month
Build the investor narrative around the constraints you have already addressed
Investors do not expect perfection. They expect awareness. Document every risk identified in this report alongside the action already taken or planned. A founder who surfaces problems is trusted more than a founder who pretends they do not exist.
Priority 03 · Next 90 Days
Improve NRR to above 100% before the raise closes
Investors value NRR above almost every other single metric at seed stage. One expansion in an existing account before the process closes changes the narrative from "good retention" to "customers grow with us." Find the most likely expansion account and pursue it specifically.
Page 19 of 17 · What comes next
Find My Constraint →
Your assessment milestone
When to run the next assessment.
Not a date. A trigger. When this specific commercial signal appears, the next constraint is ready to be assessed.
Milestone Trigger
When NRR crosses 100%, top-3 customer concentration drops below 40% of ARR, and at least one non-founder closed deal is on record, the commercial story is ready for institutional scrutiny.
Watch for these signals before the milestone
NRR crosses 100% for two consecutive months
Top-3 concentration drops below 40% of total ARR
At least one expansion or upsell is on record
Forecast accuracy improves above 75% for 2 quarters
The next assessment
Revenue Due Diligence
$1,249 · 7 days · For founders 60–90 days from a Series A or B raise
Start Revenue Due Diligence →
Page 17 of 17
The assessment is done. Here's where that puts you.
1
Awareness
2
Assessed
You are here
Planned
Next
4
Execution
5
Optimization
6
Scale
Days 1–30
🔒
Days 31–60
🔒
Days 61–90
🔒

Detailed weekly milestones, owner assignments, and KPIs available in the Wiremap Growth Plan.

The Wiremap Growth Plan

Convert this assessment into a step-by-step plan, weekly priorities, KPI tracking, and a clear sequence built around closing this exact gap before the raise.

⚡ A real fragment, Week 1 of your plan, if purchased
Owner
Founder
Action
Build a target list of 15 mid-market companies matching the profile of the two existing pilots. Begin direct outreach to 5.
KPI
3 of 5 outreach targets respond within 7 days
Done When
At least 1 new mid-market conversation is booked
This is what's inside, sequenced for every week, not just week one. A generic AI prompt can't produce this without the assessment behind it.
Recommended next health check: Before your raise process formally begins, or in 60 days, whichever comes first. Segment narrative shifts need real evidence behind them before they reach an investor's inbox.
Recommended
90-Day Growth Transformation
Best for a major growth milestone.
$299
  • Everything in the 60-Day plan
  • Full sequencing roadmap
  • Investor-readiness framework
60-Day Growth Acceleration
Best for implementing multiple recommendations.
$239
  • Everything in the 30-Day plan
  • Cross-functional sequencing
  • Progress checkpoints
30-Day Growth Sprint
Best for validating a single constraint.
$119
  • Weekly priorities
  • KPI tracking
  • Success milestones
Ask About the Growth Plan → Run My Own Assessment